Lyons Wealth Management’s Redhill Biopharma RDHL Stock Holding History

Lyons Wealth Management’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12	Closed	-$203K	–	78
2015 Q2	$203K	Buy	+12	New	+$191K	0.23%	51

Other funds holding RDHL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Lyons Wealth Management's RDHL Position: Q3 2015 in Review

Lyons Wealth Management sold out of Redhill Biopharma (RDHL) in Q3 2015, closing a stake of 12 shares — an estimated $203K sold.

Lyons Wealth Management first reported a position in RDHL in Q2 2015 and held it in 1 quarter. The position peaked at $203K in Q2 2015. 22 funds tracked by Wall St. Rank hold RDHL as of Q3 2015.

Lyons Wealth Management reported no remaining Redhill Biopharma position as of Q3 2015 after selling out during the quarter.
Lyons Wealth Management sold 12 Redhill Biopharma shares in Q3 2015, an estimated $203K.
Lyons Wealth Management first reported a position in Redhill Biopharma in Q2 2015 and held it in 1 quarter.
Lyons Wealth Management's Redhill Biopharma position peaked at $203K in Q2 2015.
22 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2015.

Based on Lyons Wealth Management's 13F filing for Q3 2015, filed 12 Nov 2015.